Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Macleods Pharma USA is recalling one lot of Levothyroxine Sodium Tablets USP 150 mcg because the product is subpotent.
Teva is recalling two lots of Octreotide Acetate for Injectable Suspension 10 mg after quality system deficiencies were identified during an FDA inspection at the contract manufacturer.
Teva is recalling nine lots of Octreotide Acetate for Injectable Suspension 20 mg after quality system deficiencies were identified during an FDA inspection at the contract manufacturer.
Amerisource Health Services is recalling one lot of Meclizine Hydrochloride Tablets USP 12.5 mg because the product failed tablet specifications.
Radnostix is recalling three lots of the Gelatin Capsule Pack used with the Sodium Iodide I-131 Kit because the product failed tablet and capsule specifications.
Cardinal Health is recalling Webcol Alcohol Prep pads because of non-sterility, with microbial contamination identified as Paenibacillus phoenicis. The FDA has classified this recall as Class I.
Apotex is recalling two lots of Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution for lack of assurance of sterility.
Strides Pharma is recalling two lots of Children's Ibuprofen Oral Suspension after complaints of a gel-like mass and black particles in the product.
Somerset Therapeutics is recalling one lot of Dexamethasone Sodium Phosphate Injection after out-of-specification impurity results at product expiry during long term stability testing.
Annora Pharma is recalling one lot of Pitavastatin Tablets 2 mg after one Pitavastatin 1 mg tablet was found in a bottle of 2 mg tablets.
Zydus Pharmaceuticals is recalling eight lots of Icosapent Ethyl Capsules 1 gram after red dots and melted capsules were found, caused by oxidation of the active ingredient.
StuffbyNainax is recalling MR. 7 SUPER 700000 capsules because FDA analysis revealed the presence of undeclared sildenafil and tadalafil. The FDA has classified this recall as Class I.
123Herbals is recalling Silintan 25-count pill bottles because FDA analysis revealed the presence of undeclared meloxicam. The FDA has classified this recall as Class I.
Mojo Max Fusion XXX capsules are being recalled because FDA analysis revealed undeclared sildenafil at 13.1 mg per capsule and tadalafil at 13.8 mg per capsule. The FDA has classified this recall as Class I.
Teva Pharmaceuticals is recalling six lots of Metoprolol Succinate Extended-Release Tablets 100 mg after the product failed dissolution specifications.
New Life Pharma is recalling one lot of Tirzepatide Injection 15 mg x 4 sterile multi-dose vials for lack of assurance of sterility.
Radnostix is recalling one batch of Sodium Iodide I-131 Therapeutic Oral Solution because of the presence of particulate matter caused by production issues.
Teva Pharmaceuticals is recalling six lots of Metoprolol Succinate Extended-Release Tablets 50 mg after the product failed dissolution specifications.
Teva Pharmaceuticals is recalling six lots of Metoprolol Succinate Extended-Release Tablets 25 mg after the product failed dissolution specifications.
New Life Pharma is recalling one lot of Semaglutide Injection 2 mg sterile multi-dose vials for lack of assurance of sterility.
New Life Pharma is recalling one lot of Tirzepatide Injection 10 mg sterile multi-dose vials for lack of assurance of sterility.
Mylan Pharmaceuticals is recalling two lots of Amnesteem (Isotretinoin) Capsules 40 mg after the product failed dissolution specifications.
New Life Pharma is recalling two lots of Semaglutide Injection 2 mg x 10 sterile multi-dose vials for lack of assurance of sterility.
Teva Pharmaceuticals is recalling three lots of Metoprolol Succinate Extended-Release Tablets 200 mg after the product failed dissolution specifications.
Rising Pharma Holding is recalling one lot of Temozolomide Capsules 5 mg after an out-of-specification result was observed during nine-month long-term stability testing.